Formulating a “repairing” product is one thing. Proving it is another. In a regulatory and competitive context where barrier repair claims are proliferating, cosmetic brands must rely on rigorous evaluation protocols, adapted to the nature of their formula and the expected level of evidence. This guide details the approaches available to concretely evaluate the repairing effect of a cosmetic formula, from study model selection to the biomarkers to measure.
Why barrier repair requires a specific protocol
Evaluating barrier repair is not the same as evaluating barrier strengthening on healthy skin. The difference is fundamental and conditions the entire study design.
To demonstrate a repairing effect, it is imperative to work on a previously impaired barrier. Without a validated challenge model, no recovery kinetics can be measured, and the claim cannot be credibly substantiated. The protocol must therefore meet three simultaneous requirements: create a standardized and reproducible impairment, measure the initial degradation, then monitor the recovery kinetics under treatment.
It is this three-step logic (impairment, baseline measurement, recovery) that distinguishes a barrier repair study from a standard hydration study.
Skin challenge models: creating a controlled impaired barrier
The SLS model: reference for chemical irritation
Sodium Lauryl Sulfate (SLS) is the most widely used and scientifically accepted challenge model for barrier repair studies. The protocol involves applying a 0.5% or 1% SLS solution under a Finn occlusive chamber (Hilltop) for 24 to 48 hours on the forearm. The induced irritation is dose- and time-dependent, which allows the intensity of impairment to be adjusted according to the level of proof required.
After removal of the patch and stabilization, the impaired baseline TEWL is measured. The test product is then applied daily on the impaired area according to the study schedule (typically D0, D3, D7, D14, D28), and TEWL is recorded at each time point to trace the recovery kinetics. An untreated control group allows spontaneous recovery to be distinguished from the product effect.
Repeated tape stripping: mechanical stratum corneum disruption
Tape stripping involves successively removing superficial layers of the stratum corneum using standardized adhesive strips (D-Squame, CuDerm). Each strip removes one or more corneal sheets. After a defined number of strips (generally 15 to 30 depending on the desired level of impairment), TEWL is measured to confirm effective disruption.
This model has several advantages: it is purely mechanical, without residual chemical irritation risk, and it allows complementary analysis of the collected strips (extracted proteins, quantification of differentiation markers, Raman lipid analysis). It is particularly suitable for studies seeking to demonstrate an effect on lipid reconstruction of the stratum corneum.
Environmental vexation model (cold/wind)
Exposure to aggressive environmental conditions (low temperature, wind, low humidity) induces barrier impairment through dehydration and physical stress. This model is used for protection and repair claims on sensitive skin exposed to winter conditions. It is less standardized than the SLS model but presents strong external validity for seasonally-used products.
| Model | Type of impairment | Reproducibility | Indicated for |
|---|---|---|---|
| SLS under occlusion | Chemical irritation | Very high | General barrier repair |
| Repeated tape stripping | Mechanical disruption | High | Lipid reconstruction, ceramide claims |
| Cold/wind vexation | Environmental stress | Moderate | Sensitive skin, winter protection |
| Detergents / surfactants | Repeated chemical irritation | High | Very dry or atopic skin formulas |
Parameters to measure to prove repair
TEWL: primary indicator of barrier recovery
Transepidermal water loss remains the reference parameter for monitoring barrier recovery. A progressive decrease in TEWL after application of the test product, compared to the impaired baseline value and the control group, constitutes direct proof of improved barrier permeability. Reference measurement equipment includes the Tewameter 300 and Nano (Courage+Khazaka), Aquaflux (Biox), Dermalab (Cortex), and Vapometer.
Measurement conditions are non-negotiable: acclimatization of at least 20 to 30 minutes in a controlled room (20°C ±1°C, 50% RH ±10%), repeated measurements on the same anatomical site, by the same operator when possible.
Stratum corneum hydration: complementary indicator
Barrier repair is generally accompanied by an improvement in hydration of the superficial corneal layers. The Corneometer® (Courage+Khazaka) remains the reference tool, measuring the electrical capacitance of the stratum corneum. Complementary measurements at different depths are possible with the MoistureMeter SC (corneal layer), MoistureMeterEpiD (epidermis), and MoistureMeterD (dermis), allowing hydration profiling in depth.
Molecular biomarkers of repair
For formulas targeting specific repair mechanisms (ceramides, filaggrin, tight junctions), molecular biomarkers allow the mechanism of action to be substantiated. The most relevant for a barrier repair study are:
| Biomarker | Function | Detection method |
|---|---|---|
| Filaggrin | Corneocyte cohesion, NMF production | Immunohistochemistry, ELISA |
| Loricrin / Involucrin | Cornified envelope, differentiation | Immunohistochemistry |
| Ceramides (subclasses) | Intercellular lipid matrix | LC-MS/MS, Raman |
| ZO1 / Occludin / Claudin 1 | Tight junctions | Immunofluorescence |
| Caspase-14 | Filaggrin degradation, NMF production | Western blot, IHC |
| TEER | Epithelial integrity (in vitro) | Franz cell, Ussing chamber |
| Kallikreins | Desquamation | ELISA, zymography |
Raman spectroscopy and confocal microscopy
For the most in-depth studies, Raman spectroscopy (gen2-SCA, RiverD) allows measurement of molecular water content across the different stratum corneum layers and evaluation of intercellular lipid organization. Confocal microscopy (Vivascope, Vivosight) provides non-invasive visualization of the three-dimensional structure of the stratum corneum, allowing architectural reorganization under treatment to be monitored without biopsy.
Designing a barrier repair study: parameters to define
Before contacting a CRO, the following points must be established:
Population: normal to dry skin for a general effect, atopic or self-declared sensitive skin for a specific positioning. Subject selection must be coherent with the target claim, and inclusion/exclusion criteria (ongoing treatments, active pathologies) rigorously defined.
Anatomical area: the forearm is the reference area for challenge models (accessibility, exploitable surface, established TEWL reference values). The face can be used for facial products, with protocols adapted to the specific reference values for that area.
Schedule: a barrier repair study includes a minimum of four measurement time points: before impairment (healthy baseline), after impairment (impaired baseline), and at least two post-treatment time points. A common schedule is D0 (impairment), D1, D7, D14, D28. Long studies (D56, D84) provide proof of durability.
Sample size: 20 to 30 subjects minimum for sufficient statistical power in an intra-individual design (each subject is their own control). A larger sample (40 to 60) is recommended for multicenter studies or claims with a high burden of proof.
Statistical design: the split-face or split-body design (treated arm vs. untreated arm on the same subject) is preferred for barrier repair studies as it controls inter-individual variability and increases statistical power.
What Skinobs references for barrier repair
Evaluating barrier repair mobilizes a combination of in vitro and in vivo methods rarely available in a single laboratory. CRO selection must integrate the availability of validated challenge models, biometrological equipment, the capacity to perform molecular and histological analyses when needed, and documented experience with this type of protocol.
On the Skinobs platform, brands access 40 referenced methods for the skin barrier, across 138 laboratories in 38 countries, with the ability to filter by study type, geographic area, and specific method.
Conclusion
Proving barrier repair requires rigorous study design: the right challenge model, the right measurement parameters, the right population, and the right schedule. TEWL remains the primary anchor, but molecular biomarkers and advanced imaging techniques allow going much further in demonstrating the mechanism of action. This depth is what makes the difference between a solid claims file and an unsubstantiated assertion.
Want to identify laboratories capable of evaluating the repairing effect of your formula? Skinobs gives you access to specialized CROs and protocols adapted to your barrier claims. [Access the platform]
